Home
Leadership
Science
- Senescence
- Diseases
Data
Media
- News
- Videos
Partners
Contact

Third Annual Healthspan Extension Policy and Regulation Workshop

Home / Events / Third Annual Healthspan Extension Policy and Regulation Workshop

09Jan 2018 by siwa-admin-2017

– Upcoming

Search for:

Recent Posts

In The News: 1000 Longevity Leaders
BIO Digital 2020
In The News: SIWA Joins the fight against COVID-19
In the News: SIWA Featured on Chicago Business Journal
In the News: SIWA Therapeutics Joins the Ranks of SpaceX, Apple & Google with Our Inclusion in MIT Technology Reviews Top 10 Breakthrough Technologies of 2020.

Archives

June 2020
May 2020
March 2020
February 2020
September 2019
March 2019
April 2018
January 2018
June 2017
May 2017
October 2016

Categories

Events
In The News
News
Press Releases

About Us

SIWA Therapeutics, Inc. is a pre-clinical stage company with a first-in-class humanized monoclonal antibody, SIWA 318H, that selectively targets both senescent cells and cancer cells.

Recent News

In The News: 1000 Longevity Leaders
BIO Digital 2020
In The News: SIWA Joins the fight against COVID-19

JOIN OUR MAILING LIST

Navigation

Home
Leadership
Science
- Senescence
- Diseases
Data
Media
- News
- Videos
Partners
Contact